Table of Contents Table of Contents
Previous Page  56 / 114 Next Page
Information
Show Menu
Previous Page 56 / 114 Next Page
Page Background

56 The US-Israel Legal Review 2019

US: CANNABIS LAW

plant,

Cannabis sativa

, but from different varieties

or cultivars that have been bred for different uses.

In fact, Hemp andMarijuana are genetically distinct

forms of cannabis that differ by their use, chemical

makeup and different cultivation practices.

There are 500 natural components found within

the

Cannabis sativa

plant, of which over 100 have

been classified as “cannabanoids,” or chemicals

that are unique to the plant. The two most well-

known are delta-9-tetrahyrdocannabinol (THC),

the psychoactive cannabinoid that gives Marijuana

users their “high,” and Cannabidiol (CBD), the

plant’s main non-psychoactive cannabinoid.

CBD can be derived from both Hemp and

Marijuana and may have therapeutic effects on

certain conditions including anxiety disorders,

movement disorders, cognition and pain. It can be

ingested in multiple ways, including by inhalation

of smoke or vapor, via an aerosol spray into the

cheek, or by mouth. It may also be supplied by

tinctures (essentially CBD-infused alcohol), CBD

oil containing only CBD as the active ingredient,

capsules or as a liquid solution. In 2017 and 2018,

CBD products spread to natural food stores, beauty

aisles and cafes. By one estimate, the CBD market

alone is poised to hit $22 billion by 2022.

FOX ROTHSCHILD CANNABIS LAW PRACTICE

Legalized cannabis is a rapidly expanding

industry in the United States, with a growing list

of jurisdictions now regulating its use for medical

and/or recreational purposes. Fox has assembled a

national team of skilled and experienced attorneys

to assist cannabis businesses at every step.

Fox has experience working for highly regulated

businesses and navigating the constantly evolving

matrix of state compliance regulations. We also

have deep experience in corporate and financing

work, including banking, entity formation and

venture capital.

Cannabis growers, distributors, processors,

investors and others also turn to Fox for practical

and efficient advice on tax issues, real estate,

intellectual property and employment law.

n

ABOUT THE AUTHORS

Bill Bogot, Partner, Co-chair Cannabis Law

Practice

Bill represents clients in highly regulated

industries, particularly gaming and cannabis.

He is co-chair of Fox’s Cannabis Law practice and

counsels clients in the medical and recreational

cannabis space in multiple states across the US

Bill is a trusted adviser to both public and private

cannabis companies. Bill is a member of the

National Cannabis Bar Association and a member

of the Editorial Board of the

Cannabis Law Journal

.

E: wbogot@foxrothschild.com

T: 312.517.9205

Joshua Horn, Partner, Co-chair Cannabis Law

Practice

Joshua understands the needs of businesses in the

rapidly expanding and highly regulated market for

legalized cannabis. He is part of a multidisciplinary

team at Fox that provides comprehensive services

and guidance to legal Marijuana businesses and

is a sought-after authority on complex cannabis

law issues. Joshua chairs the Employment Issues

Subcommittee of the Philadelphia Bar Association’s

Medical Marijuana and Hemp Committee, serves on

the Editorial Board of the Cannabis Law Journal and

is a member of the Pennsylvania Bar Association’s

Medical Marijuana and Hemp Law Committee.

E: jhorn@foxrothschild.com

T: 215.299.2184

CONTACT:

Fox Rothschild LLP

2000 Market Street, 20th Floor,

Philadelphia,

PA 19103-3222,

USA www.foxrothschild.com

By one estimate, the CBDmarket

alone is poised to hit $22 billion

by 2022.